Found: 28
Select item for more details and to access through your institution.
Validating Predicted Biological Effects of Alzheimer's Disease Associated SNPs Using CSF Biomarker Levels.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 21, n. 3, p. 833, doi. 10.3233/JAD-2010-091711
- By:
- Publication type:
- Article
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease.
- Published in:
- Human Molecular Genetics, 2012, v. 21, n. 20, p. 4558, doi. 10.1093/hmg/dds296
- By:
- Publication type:
- Article
Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants.
- Published in:
- Human Molecular Genetics, 2007, v. 16, n. 8, p. 865, doi. 10.1093/hmg/ddm031
- By:
- Publication type:
- Article
DAPK1 variants are associated with Alzheimer's disease and allele-specific expression.
- Published in:
- Human Molecular Genetics, 2006, v. 15, n. 17, p. 2560, doi. 10.1093/hmg/ddl178
- By:
- Publication type:
- Article
ABCA7 and MS4A6A expression are upregulated in Alzheimer's disease brains
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Association and expression analyses with SNPs in TOMM40 in Alzheimer's disease
- Published in:
- 2011
- By:
- Publication type:
- Abstract
APOE Genotype is Associated with Cerebrospinal Fluid and Plasma APOE Levels But Not with APOE Expression Levels
- Published in:
- 2011
- By:
- Publication type:
- Abstract
SNPs associated with CSF tau levels modify rate of progression in Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Validating predicted biological effects of Alzheimer's disease associated SNPs using cerebrospinal fluid biomarker levels
- Published in:
- 2010
- By:
- Publication type:
- Abstract
SNPs in catalytic and regulatory subunits of calcineurin are associated with CSF tau levels and mRNA levels
- Published in:
- 2009
- By:
- Publication type:
- Abstract
P3-214: Cerebrospinal fluid tau levels, an endophenotype for genetic studies of Alzheimer's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
O2-06-06: SNPS in MAPT are associated with cerebrospinal fluid Tau levels, MAPT mRNA levels, and age at onset of late-onset Alzheimer's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P1-413: SORBS1, c-ABL and c-CBL; insulin signalling proteins in Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-341: Are common variants in APP risk factors for late-onset Alzheimer’s disease?
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-299: Sorbs 1, a candidate gene for the chromosome 10 late onset Alzheimer’s disease locus
- Published in:
- 2006
- By:
- Publication type:
- Abstract
O2-02-05: Novel candidate genes for late-onset Alzheimer’s disease from a large scale association study of 20K functional variants
- Published in:
- 2006
- By:
- Publication type:
- Abstract
O2-02-07: Genetic variants on chromosome 9 are associated with late-onset Alzheimer’s disease, variation in allele-specific gene expression, and differential apoptotic response
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-413: SORBS1, c-ABL and c-CBL; insulin signalling proteins in Alzheimer’s disease
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-341: Are common variants in APP risk factors for late-onset Alzheimer’s disease?
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P1-299: Sorbs 1, a candidate gene for the chromosome 10 late onset Alzheimer’s disease locus
- Published in:
- 2006
- By:
- Publication type:
- Abstract
O2-02-07: Genetic variants on chromosome 9 are associated with late-onset Alzheimer’s disease, variation in allele-specific gene expression, and differential apoptotic response
- Published in:
- 2006
- By:
- Publication type:
- Abstract
O2-02-05: Novel candidate genes for late-onset Alzheimer’s disease from a large scale association study of 20K functional variants
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Expression of Novel Alzheimer's Disease Risk Genes in Control and Alzheimer's Disease Brains.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0050976
- By:
- Publication type:
- Article
Escitalopram reduces attentional performance in anxious older adults with high-expression genetic variants at serotonin 2A and IB receptors.
- Published in:
- International Journal of Neuropsychopharmacology, 2013, v. 16, n. 2, p. 279, doi. 10.1017/S1461145712000351
- By:
- Publication type:
- Article
α-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer’s disease.
- Published in:
- NeuroMolecular Medicine, 2004, v. 5, n. 2, p. 133, doi. 10.1385/NMM:5:2:133
- By:
- Publication type:
- Article
Genetic association of the APP binding protein 2 gene (APBB2) with late onset Alzheimer disease.
- Published in:
- Human Mutation, 2005, v. 25, n. 3, p. 270, doi. 10.1002/humu.20138
- By:
- Publication type:
- Article
Ubiquilin 1 polymorphisms are not associated with late‐onset Alzheimer's disease.
- Published in:
- Annals of Neurology, 2006, v. 59, n. 1, p. 21, doi. 10.1002/ana.20673
- By:
- Publication type:
- Article
Association of Functional Polymorphisms from Brain-Derived Neurotrophic Factor and Serotonin-Related Genes with Depressive Symptoms after a Medical Stressor in Older Adults.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0120685
- By:
- Publication type:
- Article